Literaturliste Ao.Univ.Prof.Doz.Dr.G.Heinz 1

Transkript

1 1 ORIGINALARBEITEN Heinz G, Komjati M, Korn A, Waldhäusl W: REDUCTION OF POSTPRANDIAL BLOOD GLUCOSE BY THE ALPHA-GLUCOSIDASE INHIBITOR MIGLITOL (BAY m 1099) IN TYPE II DIABETIC PATIENTS - A DOSE RESPONSE STUDY. Eur J Clin Pharmacol 1989;37:33-36 Heinz G, Öhner T, Gasic S, Laufer G, Lackovics A: CLINICAL AND ELECTRO- PHYSIOLOGIC CORRELATES OF SINUS NODE DYSFUNCTION AFTER ORTHOTOPIC HEART TRANSPLANTATION - OBSERVATIONS IN 42 PATIENTS. Chest 1990;97: Heinz G, Laufer G, Öhner T, Gasic S, Laczkovics A: ANALYSIS OF HEART RATE CHANGES IN CARDIAC TRANSPLANT RECIPIENTS RELATED TO GRAFT REJECTION. Am J Cardiol 1990;66: Heinz G, Öhner T, Laufer G, Gössinger H, Gasic S, Laczkovics A: DEMOGRAPHIC AND PERIOPERATIVE FACTORS ASSOCIATED WITH SINUS NODE DYSFUNCTION AFTER ORTHOTOPIC HEART TRANSPLANTATION: THE IMPACT OF ISCHEMIC TIME. Transplantation 1991;51: Heinz G, Laufer G, Hirschl MM, Gasic S, Siostrzonek P, Gössinger H, Laczkovics A: POSTOPERATIVE SINUS NODE DYSFUNCTION IN THE TRANSPLANTED HEART: IMPAIRED AUTOMATICITY BUT NORMAL REFRACTORINESS. Chest 1992;101: Heinz G, Hirschl MM, Buxbaum P, Laufer G, Gasic S, Laczkovics A: SINUS NODE DYSFUNCTION AFTER ORTHOTOPIC CARDIAC TRANSPLANTATION: POSTOPERATIVE INCIDENCE AND LONG-TERM IMPLICATIONS. Pace 1992;15: Heinz G, Siostrzonek P, Kreiner G, Gössinger H: IMPROVEMENT IN LEFT VENTRICULAR SYSTOLIC FUNCTION AFTER SUCCESSFUL RADIOFRE- QUENCY HIS BUNDLE ABLATION FOR DRUG REFRACTORY CHRONIC ATRIAL FIBRILLATION AND RECURRENT ATRIAL FLUTTER. Am J Cardiol 1992;69: Heinz G, Kreiner G, Binder T, Schmidinger H, Frey B, Anvari A, Weber H, Gössinger H: SUCCESSFUL RADIOFREQUENCY ABLATION IN A PATIENT WITH BOTH AV NODAL REENTRY AND CIRCUS MOVEMENT TACHYCARDIA. Am Heart J, 1993;125: Heinz G, Hirschl MM, Kratochwill Ch, Laufer G, Gössinger H, Laczkovics A: INDUCIBLE ATRIAL FLUTTER AND FIBRILLATION AFTER ORTHOTOPIC CARDIAC TRANSPLANTATION. J Heart Transpl 1993;12:517-21

2 2 Heinz G, Kratochwill Ch, Buxbaum P, Laufer G, Kreiner G, Siostrzonek P, Gasic S, Derfler K, Gössinger H: IMMEDIATE NORMALIZATION OF PROFOUND SINUS NODE DYSFUNCTION FOLLOWING CARDIAC TRANSPLANTATION BY AMINOPHYLLINE. Am J Cardiol 1993;71: Heinz G, Hirschl MM, Laufer G, Buxbaum P, Siostrzonek P, Gössinger H, Laczkovics A: THE ELECTROPHYSIOLOGY OF CARDIAC ALLOGRAFT REJECTION: INDEPENDENT EFFECTS OF REJECTION AND PERIOPERATIVE ISCHEMIA ON THE SINUS NODE RECOVERY PHENOMENON AFTER CARDIAC TRANSPLANTATION. Bas Res Cardiol 1992;87: Heinz G, Kratochwill Ch, Hirschl MM, Buxbaum P, Kreiner G, Gasic S, Gössinger H, Laczkovics A: NORMAL AV NODE FUNCTION IN PATIENTS WITH SINUS NODE DYSFUNCTON AFTER CARDIAC TRANSPLANTATION. J Cardiac Surg 1993;8: Heinz G, Kratochwill Ch, Buxbaum P, Kreiner G, Siostrzonek P, Gössinger H, Laczkovics A: LONG-TERM INTRINSIC PACEMAKER FUNCTION IN PATIENTS PACED FOR SINUS NODE DEFICIENCY AFTER CARDIAC TRANSPLANTATION. Pace 1992;15(II): Heinz G, Kreiner G, Radosztics S, Siostrzonek P, Gössinger H: MANAGEMENT OF ELDERLY PATIENTS WITH THE WOLFF-PARKINSON-WHITE SYNDROME: IS LESS AGGRESSIVE TREATMENT JUSTIFIED? Clin Invest 1993;71: Heinz G, Radosztics S, Kratochwill Ch, Kreiner G, Buxbaum P, Grimm M, Sunder- Plassmann G, Laufer G, Laczkovics A, Gössinger H: EXERCISE CHRONOTROPY IN PATIENTS WITH NORMAL AND IMPAIRED SINUS NODE FUNCTION AFTER CARDIAC TRANSPLANTATION. Pace 1993;16(9): Heinz, G: PACING AFTER CARDIAC TRANSPLANTATION. Br Heart J 1993;70/6:590 (letter) Heinz G: SINUS NODE DURING ATRIAL FIBRILLATION. Circulation 1994;89:507 (letter) Heinz G, Kratochwill C, Schmid S, Kreiner G, Siostrzonek P, Pacher R, Grimm M, Laufer G, Gössinger H: SINUS NODE DYSFUNCTION AFTER ORTHOTOPIC HEART TRANSPLANTATION - THE VIENNA EXPERIENCE Pace 1994;17: Heinz G: BRADYCARDIA AFTER HEART TRANSPLANTATION: REVERSAL WITH THEOPHYLLINE. J Am Coll Cardiol 1997;29: (letter) Heinz G, Kratochwill G, Koller-Strametz J, Kreiner G, Grimm M, Grabenwöger M, Laufer G, Gössinger H: BENIGN PROGNOSIS OF EARLY SINUS NODE DYSFUNCTION AFTER ORTHOTOPIC CARDIAC TRANSPLANTATION. PACE 1998;21(2): Heinz G: ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA. Crit Care Med 1998;26(4): (letter)

3 3 Heinz G, Geppert A, Delle Karth G, Reinelt P, Gschwandtner ME, Neunteufl T, Zauner C, Frossard M, Siostrzonek P: IV MILRINONE FOR CARDIAC OUTPUT INCREASE AND MAINTENANCE - COMPARISON IN NONHYPERDYNAMIC SIRS/SEPSIS AND CONGESTIVE HEART FAILURE. Int Care Med 1999;25:

4 4 Koller-Strametz J, Wieselthaler G, Kratochwill G, Laufer G, Pacher R, Heinz G: THROMBOEMBOLSIM ASSSOCIATED WITH JUNCTIONAL ESCAPE RHYTHM AND ATRIAL STANDSTILL AFTER ORTHOTOPIC HEART TRANSPLANTATION. J Heart Lung Transpl 1995;14: Kratochwill C, Schmid S, Koller-Strametz J, Kreiner G, Grabenwöger M, Grimm M, Laufer G, Heinz G: DECREASE OF PACEMAKER INCIDENCE AFTER CARDIAC TRANSPLANTATION. Am J Cardiol 96;77/9: Koller-Strametz J, Kratochwill Ch, Grabenwöger M, Laufer G, Pacher R, Gemeiner N, Gasic S, Heinz G: PR- INTERVAL ADAPTATION IN THE DENERVATED TRANSPLANTED HEART. Pace 1997;20: Haumer M, Geppert A, Delle Karth G, Gschwandtner ME, Neunteufl T, Zauner C, Siostrzonek P, Heinz G: TRANSIENT SWALLOW SYNCOPE DURING PERIODS OF HYPOXIA IN A 67 YEAR OLD PATIENT FOLLOWING SELF EXTUBATION. Crit Care Med 2000;28: Delle Karth, G, Geppert A, Neunteufl T, Priglinger U, Haumer M, Gschwandtner M, Siostrzonek P, Heinz G: AMIODARONE VERSUS DILTIAZEM FOR RATE CONTROL IN CRITICALLY ILL PATIENTS WITH ATRIAL TACHYARRHYTHMIAS. Crit Care Med 2001;29: Reinelt P, Delle Karth G, Geppert A, Heinz G: INCIDENCE AND TYPE OF CARDIAC ARRHYTHMIAS IN CTIRICALLY ILL PATIENTS: A SINGLE CENTER EXPERIENCE IN A MEDICAL-CARDIOLOGIC ICU. Intensive Care Med 2001;27(9): Geppert A, Steiner A, Zorn G, Delle-Karth G, Koreny M, Haumer M, Siostrzonek P, Huber K, Heinz G: MULTIPLE ORGAN FAILURE IN PATIENTS WITH CARDIOGENIC SHOCK IS ASSOCIATED WITH HIGH PLASMA LEVELS OF INTERLEUKIN-6. Crit Care Med 2002;30: Priglinger U, Delle Karth G, Geppert A, Joukhadar C, Graf S, Berger R, Hülsmann M, Spitzauer S, Pabinger I, Heinz G: PROPHYLACTIC ANTICOAGULATION WITH ENOXAPARIN IS THE SUBCUTANEOUS ROUTE APPROPRIATE IN THE CRITICALLY ILL? Crit Care Med 2003;31(5): Delle Karth G, Reinelt P, Buberl A, Geppert A, Hülsmann M, Berger R, Heinz G: CIRCADIAN VARIATION IN VENTRICULAR TACHYCARDIA AND ATRIAL FIBRILLATION IN A MEDICAL-CARDIOLOGICAL ICU. Intensive Care Med 2003;29(6):963-8

5 5 Delle Karth G, Buberl A, Geppert A, Neunteufl T, Huelsmann M, Kopp C, Nikfardjam M, Berger R, Heinz G: HEMODYNAMIC EFFECTS OF A CONTINUOUS INFUSION OF LEVOSIMENDAN IN CRITICALLY ILL PATIENTS WITH CARDIOGENIC SHOCK REQUIRING CATECHOLAMINES. Acta Anaestesiol Scand 2003;47: Koreny M, Reinelt P, Meyer B, Delle Karth G, Geppert A, Hülsmann M, Priglinger U, Berger R, Heinz G: Dynamics of inflammation parameters prior to tachyarrhythmias in critically ill patients. Wien Klin Wochenschr 2005;117:342-7 Delle Karth G, Meyer B, Bauer S, Nikfardjam M, Heinz G: OUTCOME AND FUNCTIONAL CAPACITY AFTER PROLONGED INTENSIVE CARE UNIT STAY. Wien Klin Wochenschr Jul;118(13-14): Delle Karth G, Buberl A, Nikfardjam M, Meyer B, Wollenek G, Grimm M, Lassnigg A, Brannath W, Hiesmayr M, Heinz G: ROLE OF AMIODARONE ON THE SYSTEMIC INFLAMMATORY RESPONSE INDUCED BY CARDIAC SURGERY: PROINFLAMMATORY ACTIONS. Can J Anaesth Apr;54(4): Meyer B, Huelsmann M, Wexberg P, Delle Karth G, Berger R, Moertl D, Szekeres T, Pacher R, Heinz G: N-terminal pro-b-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients Crit Care Med. 2007;35: Dick P, Mlekusch W, Delle Karth G, Nikfardjam M, Schillinger M, Heinz G: DECREASING INCIDENCE OF CRITICAL LIMB ISCHEMIA AFTER INTRA- AORTIC BALLOON PUMP COUNTERPULSATION. Angiology 2009;60: Gasic S, Heinz G, Kleinbloesem C, Korn A: EFFECTS OF ACE-INHIBITION WITH CILAZAPRIL ON SPLANCHNIC AND SYSTEMIC HEMODYNAMICS IN MAN. Br J Clin Pharm 1989;27:225S-234S Gasic S, Heinz G, Kleinbloesem C: QUANTITATIVE EVIDENCE OF PERIPHERAL CONVERSION OF ANGIOTENSIN WITHIN THE HUMAN LEG: EFFECTS OF LOCAL ANGIOTENSIN I ADMINISTRATION AND ANGIOTENSIN CONVERTING ENZYME INHIBITION ON REGIONAL BLOOD FLOW AND ANGIOTENSIN II BALANCE ACROSS THE LEG. Naunyn Schmiedebergs Archives of Pharmacology 1990;342: Hartmann D, Korn A, Komjati M, Heinz G, Haefelfinger P, Defoin R, Waldhäusl W: LACK OF EFFECT OF TENOXICAM ON DYNAMIC RESPONSE TO CONCURRENT ORAL DOSES OF GLUCOSE AND GLIBENCLAMIDE. Br J Clin Pharmac 1990;30: Gasic S, Kleinbloesem C, Heinz G, Waldhäusl W: CONTRIBUTION OF SPLANCHNIC AND PERIPHERAL VASCULAR TISSUES TO THE DISPOSAL OF ANGIOTENSIN- II AND TO REGIONAL CONVERSION RATES OF ANGIOTENSIN I: A PILOT STUDY IN HUMANS. J Cardiovasc Pharmacol 1991;17:

6 6 Gasic S, Vierhapper H, Nowotny P, Heinz G, Waldhäusl W: CONTRIBUTION OF LEG VASCULAR TISSUES TO THE OVERALL METABOLIC CLEARANCE OF HUMAN ATRIAL NATRIURETIC PEPTIDE (HANP) IN MAN. Int J Clin Pharmacol Ther Tox 1991;29: Gössinger H, Siostrzonek P, Jung M, Heinz G, Wagner L, Schwarzinger I, Stümpflen A, Mösslacher H: PREDICTION OF ELECTROPHYSIOLOGICAL ABNORMALITY IN PATIENTS WITH OTHERWISE UNEXPLAINED SYNCOPE. J Cardiovasc Electrophysiol 1991;2:2-8 Derfler K, Hayde M, Heinz G, Hirschl MM, Steger G, Hauser A, Balcke P, Widhalm K: DECREASED POSTHEPARIIN LIPOLYTIC ACTIVITY IN RENAL TRANSPLANT RECIPIENTS WITH CYCLOSPORINE A. Kidney International 1991;40: Derfler K, Kletter K, Balcke P, Heinz G, Dudczak R: PREDICTIVE VALUE OF THALLIUM-201-DIPYRIDAMOLE MYOCARDIAL STRESS SCINTIGRAPHY IN CHRONIC HEMODIALYSIS PATIENTS AND TRANSPLANT RECIPIENTS. Clinical Nephrology 1991;36(4): Siostrzonek P, Zangeneh M, Gössinger H, Lang W, Rosenmayer G, Heinz G, Stümpflen A, Zeiler K, Schwarz M, Mösslacher H: COMPARISON OF TRANSESOPHAGEAL AND TRANSTHORACIC CONTRAST ECHOCARDIOGRAPHY FOR DETECTION OF A PATENT FORAMEN OVALE. Am J Cardiol 1991;68: Hirschl MM, Derfler K, Janata O, Heinz G, Sertl K, Balcke P: ACCUMULATION OF PNEUMOCYSTIS CARINII PNEUMONIA IN PATIENTS AFTER KIDNEY TRANSPLANTATION. Clinical Nephrology 1992;37(2):105(letter) Siostrzonek P, Lang W, Zangeneh M, Gössinger H, Stümpflen A, Rosenmayer G, Heinz G, Stümpflen A, Wendelin B, Ehringer H, Mösslacher H: SIGNIFICANCE OF LEFT SIDED HEART DISEASE FOR DETECTION OF A PATENT FORAMEN OVALE. J Am Coll Cardiol 1992;19: Siostrzonek P, Koppensteiner R, Kreiner G, Madl C, Gössinger H, Heinz G, Stümpflen A, Wendelin B, Ehringer H, Mösslacher H: ABNORMAL BLOOD RHEOLOGY IN IDIOPATHIC DILATED CARDIOMYOPATHY. Am J Cardiol 1992;69: Kreiner G, Siostrzonek P, Heinz G, Pabinger I, Jung M, Gössinger H: DRUG TESTING IN PATIENTS WITH PULMONARY HYPERTENSION OF UNKNOWN CAUSE. Eur Heart J 1992;13: Sunder-Plassmann G, Heinz G, Wagner L, Prychzy B, Derfler K: T-CELL SELECTION AND TCR VARIABLE ß-CHAIN USAGE IN CHRONIC HEMODIALYSIS PATIENTS. Clin Nephrol, 1992;37(5):252-9 Laufer G, Grablowitz V, Laczkovics A, Miholic J, Heinz G, Wollenek G, Schreiner W, Wolfram J, Wolner E: THE DETERMINANTS OF ELEVATED TOTAL PLASMA CHOLESTEROL LEVELS IN CARDIAC TRANSPLANT RECIPIENTS

7 7 ADMINISTERED LOW DOSE CYCLOSPORINE FOR IMMUNOSUPPRESSION. J Thorac Cardiovasc Surgery, 1992;104(2):241-7 Siostrzonek P, Koppensteiner R, Gössinger H, Zangeneh M, Heinz G, Kreiner G, Stümpflen A, Buxbaum P, Ehringer H, Mösslacher H: HEMODYNAMIC AND HEMORHEOLOGIC DETERMINANTS OF LEFT ATRIAL SPONTANEOUS ECHO CONTRAST AND THROMBUS FORMATION IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY. Am Heart J, 1993;125: Derfler K, Hirschl MM, Fasching P, Maza Th, Heinz G, Waldhäusl W: Prognose von Typ-I/Typ-II-Diabetikern mit terminaler Niereninsuffizienz bzw. unter Nierenersatztherapie. Diabetes und Stoffwechsel 1992;1:1-6 Binder T, Porenta G, Nürnberg M, Frey B, Nitsch G, Donesch B, Heinz G, Anvari A, Kreiner G, Gössinger H, Schmidinger H, Pacher R, Weber H, Steinbach K: HEART RATE VARIABILITY AS A POTENTIAL PREDICTOR OF CARDIAC DEATH: A COMPARISON OF SPECTRAL AND NON SPECTRAL PARAMETERS. Cybernet Syst Res 1992;2: Hirschl MM, Heinz G, Sunder Plassmann G, Derfler K: RENAL REPLACEMENT THERAPY IN TYPE II DIABETIC PATIENTS: 10 YEAR EXPERIENCE. Am J Kidney Dis 1992;20(6): Hirschl MM, Derfler K, Heinz G, Sunder Plassmann G, Waldhäusl W: LONG-TERM FOLLOW-UP OF RENAL TRANSPLANTATION IN TYPE I AND TYPE II DIABETIC PATIENTS. Klin Wochenschrift=Clin Invest, 1992;70: Binder T, Frey B, Porenta G, Heinz G, Wutte M, Kreiner G, Gössinger H, Schmidinger H, Pacher R, Weber H: PROGNOSTIC VALUE OF HEART RATE VARIABILITY IN PATIENTS AWAITING CARDIAC TRANSPLANTATION. Pace 1992;15(II): Kreiner G, Heinz G, Siostrzonek P, Stümpflen A, Binder T, Gössinger H: IMPAIRED SUBSIDIARY PACEMAKER FUNCTION IN PATIENTS WITH A RIGHT BUNDLE BRANCH BLOCK CREATED PRIOR TO COMPLETE CATHETER ABLATION OF THE AV JUNCTION. Eur Heart J 1993;14: Kreiner G, Heinz G, Siostrzonek P, Radosztics S, Gössinger H: ALTERNATIONS OF ORTHODROMIC CIRCUS MOVEMENT TACHYCARDIA BY DUAL ATRIOVENTRICULAR NODAL PATHWAYS IN A PATIENT WITH THE WOLFF- PARKINSON-WHITE SYNDROME. Pace 1993;16: Hirschl MM, Seidler D, Zeiner A, Wagner A, Heinz G, Rögglia G, Laggner AN: NIFEDIPINE OR URAPIDIL FOR TREATMENT OF HYPERTENSIVE EMERGENCIES. Am J Emerg Med 1993;11(6):

8 8 Frey B, Heinz G, Kreiner G, Schmidinger H, Weber H, Gössinger H: INCREASED HEART RATE VARIABILITY AFTER RADIOFREQUENCY ENERGY ABLATION. Am J Cardiol 1993;71: Siostrzonek P, Kranz A, Heinz G, Rödler S, Gössinger H, Kreiner G, Stümpflen A, Zehetgruber M, Schwarz M, Weber H: NONINVASIVE ESTIMATION OF CORONARY FLOW RESERVE BY TRANSOESOPHAGEAL DOPPLER SONOGRAPHIC MEASUREMENT OF CORONARY SINUS FLOW. Am J Cardiol 1993;72: Siostrzonek P, Teufelsbauer H, Kreiner G, Laczkovics A, Gössinger H, Heinz G, Stümpflen A, Mösslacher H: RELIEF OF DIASTOLIC CARDIAC DYSFUNCTION AFTER CYCLOSPORINE WITHDRAWAL IN A CARDIAC TRANSPLANT RECIPIENT. Eur Heart J 1993;14: Derfler K, Swoboda K, Hirschl MM, Steger G, Heinz G, Längle F, Sunder-Plassmann G, Sauter T, Hauser AC, Druml W, Widhalm K: EVIDENCE OF PERIPHERAL INSULIN RESISTANCE BY ELEVATED BASAL AND STIMULATED C-PEPTIDE VALUES IN RENAL TRANSPLANT RECIPIENTS. Curr Ther in Nephrol 1992;4: Frey B, Heinz G, Binder T, Wutte M, Schneider B, Schmidinger H, Weber H, Pacher R: DIURNAL VARIATION OF VENTRICULAR RESPONSE TO ATRIAL FIBRILLATION IN PATIENTS WITH ADVANCED HEART FAILURE. Am Heart J, 1995;129:58-65 Pacher-R; Globits-S; Wutte-M; Rodler-S; Heinz-G; Kreiner-G; Radosztics-S; Berger-R; Presch-I; Weber-H: TI: BENEFICIAL HEMODYNAMIC EFFECTS OF PROSTAGLANDIN E1 INFUSION IN CATECHOLAMINE-DEPENDENT HEART FAILURE: RESULTS OF A PROSPECTIVE, RANDOMIZED, CONTROLLED STUDY. Crit-Care-Med 1994; 22(7): Kürkciyan-I; Sterz-F; Roden-M; Heinz-G; Hirschl-MM; Müllner-M; Laggner-AN: A NEW PREPARATION OF NIFEDIPINE FOR SUBLINGUAL APPLICATION IN HYPERTENSIVE URGENCIES. Angiology 1994; 45(7): Kreiner G, Heinz G, Gössinger HD: IMPACT OF SLOW PATHWAY ABLATION ON THE VENTRICULAR RATE DURING ATRIAL FIBRILLATION. DEPENDENCE ON THE ELECTROPHYSIOLOGICAL PROPERTIES OF THE FAST PATHWAY. Circulation 1996;93(2): Pacher-R; Stanek-B; Hulsmann-M; Koller-Strametz-J; Berger-R; Schuller-M; Hartter-E; Ogris-E; Frey-B; Heinz-G; Maurer-G: PROGNOSTIC IMPACT OF BIG ENDOTHELIN- 1 PLASMA CONCENTRATIONS COMPARED WITH INVASIVE HEMODYNAMIC EVALUATION IN SEVERE HEART FAILURE. J-Am-Coll-Cardiol. 1996;27(3): Roeggla M, Heinz G, Werba E, Roeggla G: CARDIAC TAMPONADE IN A 21-YEAR OLD BODY BUILDER WITH ANABOLICA ABUSE. BJCP 1996;50(7): 441 (letter)

9 9 Gwechenberger M, Katzenschlager R, Heinz G, Gottsauner-Wolf M, Probst P: USE OF A COLLAGEN PLUG VERSUS MANUAL COMPRESSION FOR SEALING ARTERIAL PUNCTURE SITE AFTER CARDIAC CATHETERIZATION. Angiology 1997;23: Gschwandtner ME, Panzer S, Bodinger C, Neunteufl T, Zauner C, Heinz G, Maurer G, Siostrzonek P: DOCUMENTED SUDDEN ONSET OF PSEUDOTHROMBO CYTOPENIA. Ann Hematol 1997;74: Christ C, Mundigler G, Merhaut C, Zehetgruber M, Kratochwill C, Heinz G, Siostrzonek P: ADVERSE CARDIOVASCULAR EFFECTS OF KETAMINE INFUSION IN PATIENTS WIHT CATECHOLAMINE DEPENDENT HEART FAILURE. Anaesth Intens Care 1997;25: Kreiner G, Heinz G, Frey B, Gössinger HD: DEMONSTRATION OF RETROGRADE CONDUCTION OVER AN ATRIOFASCICULAR ACCESSORY PATHWAY. J Cardiovasc Electrophysiol 1997;8(1):74-9 Globits S, Kreiner G, Frank H, Heinz G, Klaar U, Frey B, Gössinger H: SIGNIFICANCE OF MORPHOLOGICAL ABNORMALITIES DETECTED BY MRI IN PATIENTS UNDERGOING SUCCESSFUL ABLATION OF RIGHT VENTRICULAR OUTFLOW TRACT TACHYCARDIA. Circulation 1997;96: Zehetgruber M, Mundigler G, Christ G, Merhaut C, Klaar U, Kratochwill C, Neunteufl T, Hofmann S, Heinz G, Maurer G, Siostrzonek P: RELATION OF HEMODYNAMIC VARIABLES TO AUGMENTATION OF LEFT ANTERIOR DESCENDING CORONARY FLOW BY INTRAAORTIC BALLOON PULSATION IN CORONARY ARTERY DISEASE. Am J Cardiol 1997;80: Röggla G, Heinz G, Werba E, Hauser I, Röggla M: HERZBEUTELTAMPONADE BEI EINEM 21-JÄHRIGE KRAFTSPORTLER NACH ANABOLIKA-ABUSUS. Der Internist 1998; Frey B, Kreiner G, Binder T, Heinz G, Baumgartner H, Gössinger HD: RELATION BETWEEN LEFT ATRIAL SIZE AND SECONDARY ATRIAL ARRHYTHMIAS AFTER SUCCESSFUL CATHETER ABLATION OF COMMON ATRIAL FLUTTER. Pace 1997;20(I): Banyai Falger S, Gottsauner Wolf M, Stepan E, Stroble W, Jansen M, Heinz G, Hörl WH, Derfler K: LIPOPROTEIN PATTERNS IN END STAGE RENAL DISEASE AND FOLLOWING RENAL TRANSPLANTATION. Clin Transplant 1997;11: Geppert A, Zorn G, Delle Karth G, Haumer M, Gwechenberger M, Koller-Strametz J, Heinz G, Huber K, Siostrzonek P: SOLUBLE SELECTINS AND THE SYSTEMIC INFLAMMATORY SYNDROME (SIRS) AFTER SUCCESSFUL CARDIOPULMONARY RESUSCITATION. Crit Care Med 2000;28:

10 10 Koller-Strametz J, Fritzer M, Gwechenberger M, Geppert A, Heinz G, Haumer M, Koreny M, Maurer G, Siostrzonek P: ELEVATION OF PROSTATE SPECIFIC MARKERS FOLLOWING CARDIOPULMONARY RESUSCITATION. Circulation 2000;102: Schindler K, Zauner C, Buchmayer H, Födinger M, Wölfl G, Bieglmayer C, Heinz G, Wilfing A, Hörl WH, Sunder-Plassmann G: HIGH PREVALENCE OF HYPERHOMOCYSTEINEMIA IN CRITICALLY ILL PATIENTS. Crit Care Med 2000;28: Koreny M, Heinz G, Geppert A, Delle Karth G, Neunteufl T, Siostrzonek P: MECHANICAL VENTILATION AND INTRA-AORTIC COUNTERPULSATION IN CARDIOGENIC SHOCK. Intens Care Med 2000;26:356 Banyai Martin, Thalhammer Florian, Menyawi IE, Heinz G, Traunmüller F, Siostrzonek P: PHARMACOKINETICS OF CEFPIROME DURING CONTINUOUS VENOVENOUS HEMOFILTRATION: RATIONALE FOR AN 8-HOUR DOSING INTERVAL. Clinical Pharmacol Ther 2000;67: Födinger M, Buchmayer H, Heinz G, Papagiannopoulos M, Kletzmayer J, Rasoul- Rockenschaub S, Hörl W, Sunder Plassmann G: EFFECT OF MTHFR 1298A C AND MTHFR 677C T GENOTYPES ON TOTAL HOMODYSTEINE, FOLATE AND VITAMIN B 12 PLASMA CONCENTRATIONS IN KIDNEY GRAFT RECIPIENTS. J Am Soc Nephrol 2000;11: Siostrzonek P, Koreny M, Delle Karth G, Haumer M, Koller-Strametz J, Heinz G: MILRINONE THERAPY IN CATECHOLAMINE DEPENDENT CRITICALLY ILL PATIENTS WITH HEART FAIURE. Acta Anaestesiol Scand 2000;44: Koreny M, Heinz G, Geppert A, Neunteufl T, Glogar D, Kiss K, Wexberg P, Siostrzonek P: SUCESSFUL EMERGENCY PERCOUTANEOUS CARDIOPULMONARY SUPPORT DURING CORONARY INTERVENTION IN AN 80-YEAR OLD PATIENT. Wie Kli Wo 2000;112: Koreny M, Geppert A, Wutte M, Delle Karth G, Heinz G, Siostrzonek P: EFFECTS OF MILRINONE ON PULMONARY GAS EXCHANGE IN CATECHOLAMINE- DEPENDENT HEART FAILURE. Am J Cardiol. 2000;86: Schmaldienst S, Banyai S, Stulnig T, Heinz G, Jansen M, Hörl WH, Derfler K: PROSPECTIVE RANDOMISED CORSS-OVER COMPARISON OF THREE LDL APHERESIS SYSTEMS IN STATIN PRETREATED PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA. Ahterosclerosis 2000;151: Geppert A, Zorn G, Heinz G, Huber K, Siostrzonek P: SOLUBLE SELECTINS IN THE PULMONARY AND SYSTEMIC CIRCULATION IN ACUTE CARDIOGENIC AND NON CARDIOGENIC PULMONARY FAILURE. Int Care Med 2001;27:

11 11 Geppert A, Zorn G, Delle Karth G, Heinz G, Maurer G, Siostrzonek P, Huber K: PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1 AND OUTCOME AFTER SUCCESSFUL CARDIOPULMONARY RESUSCTITATION. Crit Care Med 2001;29: Födinger M, Buchmayer H, Heinz G, Papagiannopoulos M, Kletzmayr J, Perschl A, Vychytil A, Hörl WH, Sunder-Plassmann G: ASSOCIATION OF TWO MTHFR POLYMORPHISMS WITH TOTAL HOMOCYSTEINE PLASMA LEVELS IN DIALYSIS PATIENTS. Am J Kidney Dis. 2001;38(1):77-84 Koreny M, Koller Strametz J, Geppert A, Delle Karth G, Heinz G, Maurer G, Siostrzonek P: ELEVATION OF PROSTATIC MARKERS FOLLOWING CARDIOGENIC SHOCK. Int Care Med. 2001;27(2):447 Kopp CW, Binder T, Grimm M, Merl O, Thalhammer F, Ullrich R, Heinz G, Mundigler G, Steffenelli T, Maurer G, Baumgartner H, Zehetgruber M: IMAGES IN CARDIOVASCULAR MEDICINE. LEFT VENTRICULAR ECHINOCOCCOSIS WITH PERIPHERAL EMOLIZATION. Circulation 2002;106: Goldammer A, Wiltschnig S, Heinz G, Jansen M, Stulnig T, Horl WH, Derfler K. ATORVASTATIN IN LOW-DENSITY LIPOPROTEIN APHERESIS-TREATED PATIENTS WITH HOMOZYGOUS AND HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA. Metabolism 2002;51(8): Joukhadar C, Klein N, Mayer BX, Kreischitz N, Delle-Karth G, Palkovits P, Heinz G, Muller M. PLASMA AND TISSUE PHARMACOKINETICS OF CEFPIROME IN PATIENTS WITH SEPSIS. Crit Care Med 2002;30(7): Koreny M, Karth GD, Geppert A, Neunteufl T, Priglinger U, Heinz G, Siostrzonek P. PROGNOSIS OF PATIENTS WHO DEVELOP ACUTE RENAL FAILURE DURING THE FIRST 24 HOURS OF CARDIOGENIC SHOCK AFTER MYOCARDIAL INFARCTION. Am J Med 2002;112(2):115-9 Meyer B, Gendy SA, Delle Karth G, Locker G, Heinz G, Jaeger W, Thalhammer F: HOW TO CALCULATE CLEARANCE OF HIGHLY PROTEIN-BOUND DRUGS DURING CONTINUOUS VENOVENUOUS HEMOFILTRATION DEMONSTRATED WITH FLUCLOXACILLIN. Kidney Blood Press Res 2003;26: Geppert A, Steiner A, Delle-Karth G, Heinz G, Huber K. USEFULNESS OF PROCALCITONIN FOR DIAGNOSING COMPLICATING SEPSIS IN PATIENTS WITH CARDIOGENIC SHOCK. Intensive Care Med. 2003; 2003;29(8): Zeitlinger MA, Marsik C, Georgopoulos A, Muller M, Heinz G, Joukhadar C. TARGET SITE BACTERIAL KILLING OF CEFPIROME AND FOSFOMYCIN IN CRITICALLY ILL PATIENTS. Int J Antimicrob Agents Jun;21(6):562-7.

12 12 Joukhadar C, Klein N, Dittrich P, Zeitlinger M, Geppert A, Skhirtladze K, Frossard M, Heinz G, Muller M: TARGET SITE PENETRATION OF FOSFOMYCIN IN CRITICALLY ILL PATIENTS. J Antimicrob Chemother 2003 May;51(5): Geppert A, Zorn G, Delle-Karth G, Koreny M, Siostrzonek P, Heinz G, Huber K: PLASMA CONCENTRATIONS OF VON WILLEBRAND FACTOR AND INTRACELLULAR ADHESION MOLECULE-1 FOR PREDICTION OF OUTCOME AFTER SUCCESSFUL CARDIOPULMONARY RESUSCITATION. Crit Care Med Mar;31(3): Delle Karth G, Koreny M, Binder T, Knapp S, Zauner C, Valentin A, Honninger R, Heinz G, Siostrzonek P. COMPLICATED INFECTIVE ENDOCARDITIS NECESSITATING ICU ADMISSION: CLINICAL COURSE AND PROGNOSIS. Crit Care 2002 Apr;6(2): Willfort-Ehringer A, Ahmadi R, Gruber D, Gschwandtner ME, Haumer A, Heinz G, Lang W, Ehringer H. EFFECT OF CAROTID ARTERY STENTING ON THE EXTERNAL CAROTID ARTERY. J Vasc Surg Nov;38(5): Zeitlinger MA, Dehghanyar P, Mayer BX, Schenk BS, Neckel U, Heinz G, Georgopoulos A, Muller M, Joukhadar C: RELEVANCE OF SOFT-TISSUE PENETRATION BY LEVOFLOXACIN FOR TARGET SITE BACTERIAL KILLING IN PATIENTS WITH SEPSIS. Antimicrob Agents Chemother Nov;47(11): Willfort-Ehringer A, Ahmadi R, Gschwandtner ME, Haumer A, Heinz G, Lang W, Ehringer H: HEALING OF CAROTID STENTS: A PROSPECTIVE DUPLEX ULTRASOUND STUDY. J Endovasc Ther Jun;10(3): Geppert A, Steiner A, Delle-Karth G, Heinz G, Huber K. USEFULNESS OF PROCALCITONIN FOR DIAGNOSING COMPLICATING SEPSIS IN PATIENTS WITH CARDIOGENIC SHOCK. Intensive Care Med Aug;29(8): Zeitlinger MA, Marsik C, Georgopoulos A, Muller M, Heinz G, Joukhadar C: TARGET SITE BACTERIAL KILLING OF CEFPIROME AND FOSFOMYCIN IN CRITICALLY ILL PATIENTS. Int J Antimicrob Agents Jun;21(6):562-7 Meyer B, Ahmed El Gendy S, Delle Karth G, Locker GJ, Heinz G, Jaeger W, Thalhammer F: HOW TO CALCULATE CLEARANCE OF HIGHLY PROTEIN- BOUND DRUGS DURING CONTINUOUS VENOVENOUS HEMOFILTRATION DEMONSTRATED WITH FLUCLOXACILLIN. Kidney Blood Press Res. 2003;26(2): Joukhadar C, Klein N, Dittrich P, Zeitlinger M, Geppert A, Skhirtladze K, Frossard M, Heinz G, Muller M: TARGET SITE PENETRATION OF FOSFOMYCIN IN CRITICALLY ILL PATIENTS. J Antimicrob Chemother May;51(5): Geppert A, Zorn G, Delle-Karth G, Koreny M, Siostrzonek P, Heinz G, Huber K. PLASMA CONCENTRATIONS OF VON WILLEBRAND FACTOR AND INTRACELLULAR ADHESION MOLECULE-1 FOR PREDICTION OF OUTCOME

13 13 AFTER SUCCESSFUL CARDIOPULMONARY RESUSCITATION. Crit Care Med Mar;31(3): Delle Karth G, Heinz G: Levosimendan in cardiology and intensive care medicine. Wie Klin Wochenschr 2004;116:6-14 Steiner I, Langenberger H, Marsik C, Mayer BX, Fischer M, Georgopoulos A, Müller M, Heinz G, Joukhadar C: EFFECT OF NOREPINEPHRINE ON CEFPIROME TISSUE CONCENTRATIONS IN HEALTHY SUBJECTS. J Antimicrob Chemother Mar;53(3): Meyer B, Kornek GV, Nikfardjam M, Delle Karth G, Heinz G, Locker GJ, Jaeger W, Thalhammer F: MULTIPLE DOSE PHARMACOKINETICS OF LINEZOLID DURING CONTINUOUS VENOVENOUS HEMOFILTRATION. J Antimicrob Chemother Jul;56(1): Epub 2005 May 19. Delle Karth, G, Schillinger M, Geppert A, Haumer M, Gwechenberger M, Meyer B, Heinz G, Siostrzonek P: IBUTILIDE FOR RAPID CONVERSION OF ATRIAL FIBRILLATION OR FLUTTER IN A MIXED CRITICALLY ILL PATIENT POPULATION. Wien Klin Wochenschr Feb;117(3):92-7. Geppert A, Dorninger A, Delle Karth G, Zorn G, Heinz G, Huber K: PLASMA CONCENTRATIONS OF INTERLEUKIN-6, ORGAN FAILURE, VASOPRESSOR SUPPORT AND SUCCESSFUL CORONARY REVASCULARIZATION IN PREDICTING 30-DAY MORTALITY OF PATIENTS WITH CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION. Crit Care Med 2006;34: Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, Schellongowski P, Angermayr B, Kitzberger R, Warszawska J, Holzinger U, Schenk P, Madl C: HYPOXIC HEPATITIS.: UNDERLYING CONDITIONS AND RISK FACTORS FOR MORTALITY IN CRITICALLY ILL PATIENTS. Intensive Care Med 2009;35:1397 Burgmann H, Stoiser B, Heinz G, Schenk P, Apfalter P, Zedtwitz-Liebenstein K, Frass M, Carmeli Y: LIKELYHOOD OF INADEQUATE TREATMENT: A NOVEL APPROACH TO EVALUATING DRUG-RESISTANCE PATTERNS. Inf Control Hosp Epidemiol 2009;30: Jarai R, Fellner B, Haoula D, Jordanova N, Heinz G, Delle Karth G, Huber K, Geppert A: EARLY ASSESSMENT OF OUTCOME IN CARDIOGENIC SHOCK: RELEVANCE OF PLASMA N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE AND INTERLEUKIN-6-LEVELS. Crit Care Med 2009;37:

14 14 Teilnahme Multizentrische Studien: Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss Y, Benbenishty J, Kalenlka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J: HYDROCROTISONE THERAPHY FOR PATIENTS WITH SEPTIC SHOCK. New Engl J Med 2008;358: Dzavík V, Cotter G, Reynolds HR, Alexander JH, Ramanathan K, Stebbins AL, Hathaway D, Farkouh ME, Ohman EM, Baran DA, Prondzinsky R, Panza JA, Cantor WJ, Vered Z, Buller CE, Kleiman NS, Webb JG, Holmes DR, Parrillo JE, Hazen SL, Gross SS, Harrington RA, Hochman JS; SHould we inhibit nitric Oxide synthase in Cardiogenic shock 2 (SHOCK-2) investigators: EFFECT OF NITRIC OXIDE SYNTHASE INHIBITION ON HAEMODYNAMICS AND OUTCOME OF PATIENTS WITH PERSISTENT CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION: A PHASE II DOSE-RANGING STUDY. Eur Heart J 2007;28: The TRIUMPH study investigators: EFFECT OF TILARGININE ACETATE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND CARDIOGENIC SHOCK. THE TRIUMPH RANDOMIZED CONTROLLED TRIAL. JAMA 2007;297: (zum Zeitzpunkt des Abbruchs waren wir weltweit das Zentrum mit den meisten inkludierten Patienten/Zentrum)

15 15 ÜBERSICHTSARBEITEN, EDITORIALS, BUCHBEITRÄGE Heinz G, Laufer G, Laczkovics A: SINUSKNOTENFUNKTIONSDIAGNOSTIK NACH ORTHOTOPER HERZTRANSPLANTATION - PHYSIOLOGIE UND PATHOPHYSIOLOGIE. Labor Aktuell 4/1991 Heinz G: METHODIK DER TEMPORÄREN EPIKARDIALEN STIMULATION AM DENERVIERTEN, TRANSPLANTIERTEN MENSCHLICHEN HERZEN - DAS HERZTRANSPLANTAT ALS KLINISCH PHARMAKOLOGISCHES MODELL. In: Kümmerle, Hitzenberger, Spitzy (Herausgeber): Klinische Pharmakologie. Grundlagen, Methoden, Pharmakotherapie. Lehr und Handbuch für die Praxis. 34. Ergänzungslieferung, 4. Auflage, ECOMED VerlagsGesmBH 11/91. III , Seiten 1-6 Heinz G, Kreiner G, Gössinger H: ABLATION VON AV KNOTEN TACHYKARDIEN: NEUE ASPEKTE ZU MECHANISMUS UND THERAPIE. Sonderband Wie Med Wo, 1992;142: Heinz G: DAS SICK SINUS SYNDROM NACH ORTHOTOPER HERZTRANSPLANTATION. Wi Kli Wo 1993;105(19): Heinz G: DIFFERENTIALDIAGNOSE VON BREITKOMPLEXTACHYKARDIEN. Sonderband anläßlich des 25. Intensivmedizinisches Symposion, Schloß Korb, Südtirol Heinz G: INTRA-AORTALE GEGENPULSATION: PRINZIP, MECHANISMUS UND STELLENWERT IM KARDIOGENEN SCHOCK. Der Mediziner1998;11-12:32-35 Heinz G: INFEKTION, SEPSIS UND KARDIALE RHYTHMUSSTÖRUNGEN. Wie Klin Wochenschr 1999;111/21: Heinz G: Eine EINE 59 JÄHRIGE PATIENTIN MIT KOMPLIZIERTEM MYOKARDINFARKT UND KARDIOGENEN SCHOCK. Sonderband Heinz G: HAT LIDOCAIN NOCH EINEN STELLENWERT IN DER INTENSIV UND NOTFALLMEDIZIN? Intensiv-News, Editorial. 10/2000 Delle Karth G, Heinz G: LEVOSIMENDAN - ANWENDUNG IN DER INTENSIVMEDIZIN UND BEI KARDIOGENEM SCHOCK. Journal für Kardiologie 2002;9(suppl E): Heinz G: KARDIOGENER SCHOCK. MedReport 2004;28(Nr.A8):2, Blackwell Verlag, Heinz G: KARDIOGENER SCHOCK. Universum Innere Medizin, Sonderausgabe anläßlich der 35. Jahrestagung der ÖGIM 2004, 2004:S46-47 Heinz G: KARDIOGENER SCHOCK - WAS GIBT ES NEUES? CliniCum 7-8/2005, S23-24 Heinz G: RHYTHMUSSTÖRUNGEN AUF DER INTENSIVSTATION.

16 16 Universum Innere Medizin, Sonderausgabe anläßlich der 35. Jahrestagung der ÖGIM 2005, S Heinz G: UPDATE KARDIOGENER SCHOCK. Intensive News 1/2006;12-15 Heinz G: Atrial fibrillation in the ICU. Editorial. Inensive Care Med 2006;32: Kardiogener Schock Gegenwart und Perspektiven. Buchbeitrag in: Eckart, Forst, Burchardi (Hrsg). Intensivmedizin, Loseblattwerk, ECOMED Verlag. November 2007 Heinz G.: Herzrhythmusstörungen. Beitrag zum Vortrag anläßlich der ÖGIM Fortbbildung "Medizin Compact", erschienen in: Innere Medizin Compact Report. Ausgabe 6/2007, S3-7 Heinz G: Arrhythmias in the ICU what do we know? J Resp Crit Care Med 2008;178:1-2 Delle Karth G, Heinz G: How to slow the Pace. Crit Care Med 2009;37: Gössinger H, Kreiner G, Heinz G, Siostrzonek P: Differentialdiagnose tachykarder Herzrhythmusstörungen und ihre Bedeutung für die Therapieentscheidung. Wie Med Wo 1994;14/15: Siostrzonek P, Geppert A, Delle Karth G, Frossard M, Heinz G: Einsatzmöglichkeiten von Phosphodiesteraseinhibitoren bei Herzinsuffizienz. Kongressband, Kapruner Herztage 1997 Siostrzonek P, Sterz F, Heinz G: Mechanischer Kreislaufersatz. Journal für Kardiologie 1999;6:79-86 Update Experten Hearing 4. Oktober 2002, Wien. Kurzzeitbehandlung der akut dekompensierten Herzinsuffizienz - Stellenwert von Levosimendan. New Drug Statement.. Update Nr 34/Dezember 2002, ISBN

17 17